Table 4 Parameters predicting retrospective consent
From: Retrospective agreement and consent to neurocritical care is influenced by functional outcome
Consent to treatment OR (95% CI) | P value | |
|---|---|---|
Univariate analysis | ||
Demographic data | ||
Age | 2.800 (0.350-5.808) | 0.1057 |
Sex: female | 3.407 (0.438-8.071) | 0.1853 |
Mechanical ventilation | 3.082 (0.414-22.923) | 0.2716 |
Funct. status preadmission | 1.263 (0.380-4.203) | 0.7033 |
Diagnosis | ||
Ischemia | 0.440 (0.316-0.612) | <0.0001 |
ICH | 0.441 (0.312-0.625) | <0.0001 |
SAH | 1.408 (0.689-2.880) | 0.3482 |
Meningoencephalitis | 4.019 (1.908-8.470) | 0.0003 |
Epilepsy | 2.627 (1.581-4.363) | 0.0002 |
GBS/MG | 3.560 (1.313-9.650) | 0.0126 |
Neurodeg./Encephalopathy | 0.872 (0.764-1.031) | 0.0219 |
Cerebral neoplasm | 0.623 (0.453-0.824) | 0.0038 |
Intoxication | 1.259 (0.853-1.738) | 0.6432 |
Functional status at 1 year after discharge | ||
mRS | 0.588 (0.538-0.642) | <0.0001 |
Multivariate analysis | ||
Ischemia | 0.294 (0.169-0.509) | <0.0001 |
ICH | 0.306 (0.173-0.541) | <0.0001 |
Meningoencephalitis | 1.076 (0.426-2.721) | 0.8764 |
Epilepsy | 0.568 (0.274-1.179) | 0.1289 |
GBS/MG | 0.698 (0.218-2.230) | 0.5426 |
Neurodeg./Encephalopathy | 0.821 (0.691-1.368) | 0.2574 |
Cerebral neoplasm | 0.572 (0.378-0.911) | 0.0097 |
mRS | 0.610 (0.555-0.671) | <0.0001 |